This Webinar will give you answers to the following questions:
What are the conceptual differences deciphered from the guidance and even more...?
Where do we put more focus: QbD, PPQ or CPV? & Why?
Where do my legacy products fit in?
Are the regulators really trying to tell us something?
What is my organization's PV maturity level? Attend and get a solid measurement checklist.
About the Presenter
Ajay Pazhayattil is an industrial pharmacist with 20+ years of pharmaceutical operational experience. He has been with N.American Brand, Generic and CDMO organizations in management roles prior to his consulting assignments. Ajay has had the opportunity to successfully remediate process validation warning letter scenarios at multiple high volume pharmaceutical organizations. He is a contributing author, speaker, committee lead and influencer in the industry. Ajay has been part of developing regulatory acceptable unique process validation solutions specific for high volume generic manufacturers.
/ pazhayattil